» zurück zur Übersicht
2017 | 05.–09. Dezember, San Antonio, Texas
40th Annual San Antonio Breast Cancer Symposium
Since 1977, the Symposium’s mission has been to provide state-of-the-art
information on breast cancer research. From a one-day regional
conference, the Symposium has grown to a five-day program attended by a
broad international audience of academic and private researchers and
physicians from over 90 countries.
The Symposium aims to achieve a balance of clinical, translational, and
basic research, providing a forum for interaction, communication, and
education for a broad spectrum of researchers, health professionals, and
those with a special interest in breast cancer.
In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health
Science Center San Antonio and the American Association for Cancer
Research (AACR) announced a collaboration for the future of the San
Antonio Breast Cancer Symposium. The Symposium has been renamed the
CTRC-AACR San Antonio Breast Cancer Symposium. Complementing the
clinical strengths of the highly regarded annual San Antonio Breast
Cancer Symposium, the AACR's scientific prestige in basic, translational
and clinical cancer research will create a unique and comprehensive
scientific meeting that will advance breast cancer research for the
benefit of patients.
In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.
C. Kent Osborne, MD, Director, Professor of Medicine and Molecular and
Cellular Biology, Director, Dan L. Duncan Cancer Center, Baylor College
of Medicine, Virginia G. Kaklamani, MD, Professor of Medicine, Division
of Hematology/Oncology, UT Health San Antonio and Carlos L. Arteaga, MD,
Professor of Medicine and Cancer Biology, Associate Director for
Clinical Research, Director Breast Cancer Program Vanderbilt-Ingram
Cancer Center, Vanderbilt University are Co-Directors of the Symposium.
Website der Veranstaltung: www.sabcs.org/Symposium-Overview